Pharmacovigilance for evaluating adverse drug reactions: value, organization, and methods

Joint Bone Spine. 2006 Dec;73(6):629-32. doi: 10.1016/j.jbspin.2006.09.002. Epub 2006 Oct 12.

Authors

Jean-Louis Montastruc¹, Agnès Sommet, Isabelle Lacroix, Pascale Olivier, Geneviève Durrieu, Christine Damase-Michel, Maryse Lapeyre-Mestre, Haleh Bagheri

Affiliation

¹ Medical and clinical pharmacology laboratory, pharmacoepidemiology unit, EA 3696, IFR Inserm 126, Paul-Sabatier university, school of medicine, Toulouse, France. [email protected]

PMID: 17110152
DOI: 10.1016/j.jbspin.2006.09.002

No abstract available

Publication types

Review

MeSH terms

Adverse Drug Reaction Reporting Systems / organization & administration*
Drug-Related Side Effects and Adverse Reactions*
Humans
Pharmacoepidemiology / methods*
Pharmacoepidemiology / organization & administration*
Product Surveillance, Postmarketing*